Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Tsuruha HoldingsTSUSF 61 3-Year EBITDA Growth Rate is 0.20% as of Feb. 2026, which is 98% below its 10-year median of 11.60. GuruFocus rates TSUSF with a GF Score™ of 61/100 and a GF Value™ of $11.38. The stock has 6 warning signs investors should review. Among 527 Healthcare Providers & Services companies, Tsuruha Holdings ranks worse than 69.26% on this metric.
During the past 12 months, Tsuruha Holdings's average EBITDA Per Share Growth Rate was -7.10% per year.
During the past 3 years, the average EBITDA Per Share Growth Rate was 0.20% per year.
During the past 5 years, the average EBITDA Per Share Growth Rate was -0.60% per year.
During the past 10 years, the average EBITDA Per Share Growth Rate was 4.50% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Tsuruha Holdings was 18.00% per year. The lowest was -1.30% per year. And the median was 11.60% per year.
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
Tsuruha Holdings 3-Year EBITDA Growth Rate Related Terms
For the Pharmaceutical Retailers subindustry, Tsuruha Holdings's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tsuruha Holdings 3-Year EBITDA Growth Rate vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Tsuruha Holdings's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where Tsuruha Holdings's 3-Year EBITDA Growth Rate falls into.
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of 0.20% mean?
Tsuruha Holdings (TSUSF) has a 3-Year EBITDA Growth Rate of 0.20% as of Feb. 2026. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Tsuruha Holdings and its competitors. This is 98% below median its historical median of 11.60. According to the industry distribution chart, Tsuruha Holdings ranks #365 out of 527 companies in the Healthcare Providers & Services industry, placing it in the top 69.3%.
Is Tsuruha Holdings' 3-Year EBITDA Growth Rate too high?
Tsuruha Holdings' current 3-Year EBITDA Growth Rate of 0.20% is 98% below median its 10-year median of 11.60. The Healthcare Providers & Services industry median 3-Year EBITDA Growth Rate is 10.20. Tsuruha Holdings' value of 0.20% is 98% below this industry median. Based on the distribution chart, Tsuruha Holdings ranks #365 out of 527 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Tsuruha Holdings has a GF Score™ of 61/100, reflecting its overall financial health beyond just this single metric.
How does Tsuruha Holdings' 3-Year EBITDA Growth Rate compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Tsuruha Holdings ranks #365 out of 527 companies for 3-Year EBITDA Growth Rate. This places Tsuruha Holdings in the lower half of its industry. The industry median 3-Year EBITDA Growth Rate is 10.20. Tsuruha Holdings' value of 0.20% is 98% below this benchmark. While the company's 10-year median is 11.60 vs. the industry median of 10.20, Tsuruha Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Healthcare Providers & Services company?
The median 3-Year EBITDA Growth Rate among Healthcare Providers & Services companies is 10.20, based on 527 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Tsuruha Holdings's current 3-Year EBITDA Growth Rate of 0.20% is 98% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Tsuruha Holdings and its competitors. For the Healthcare Providers & Services industry, the median 3-Year EBITDA Growth Rate is 10.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Tsuruha Holdings's current 3-Year EBITDA Growth Rate is 0.20%, which is 98% below median its own 10-year median of 11.60. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tsuruha Holdings stock overvalued right now?
Tsuruha Holdings (TSUSF) has a current 3-Year EBITDA Growth Rate of 0.20%. The stock's GF Value™ is $11.38, compared to a current price of $17.25 — trading 51.6% above its estimated fair value. The current 3-Year EBITDA Growth Rate is 0.20%, which is 98% below median its 10-year median of 11.60 and 98% below the Healthcare Providers & Services industry median of 10.20. Tsuruha Holdings' overall GF Score™ is 61/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Tsuruha Holdings (TSUSF), the current 3-Year EBITDA Growth Rate is 0.20% as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Tsuruha Holdings (TSUSF) Overvalued in 2026?
Based on GuruFocus' analysis, Tsuruha Holdings stock appears to be overvalued.
The current stock price of $17.25 is trading 51.6% above its estimated GF Value™ of $11.38.
Key valuation signals for TSUSF:
3-Year EBITDA Growth Rate: 0.20% (98% below median its 10-year median of 11.60)
GF Value™: $11.38 vs. price of $17.25 (51.6% above fair value)
Industry Position: 98% below the Healthcare Providers & Services median (#365 of 527)
No single metric tells the full story. See the TSUSF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Tsuruha Holdings Inc manages pharmaceutical companies in Japan, where the drugstore business is the core of their operations. The company generates revenue through selling prescription and over-the-counter drugs, medical supplies, nursing care products, discount cosmetics, health products, and a miscellaneous assortment of general merchandise. It also provides blood testing services, disease prevention solutions, and at-home drug delivery services.
61GF Score
Get the complete analysis for TSUSF
3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSUSF has been successfully added to your 
